GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • CHICAGO, May 1- Iowa Governor Terry Branstad declared a state of emergency on Friday due to a rapidly expanding avian flu outbreak, soon after state agriculture officials announced four new poultry farms had initially tested positive for the virus. Iowa, the top egg-producing state in the United States, is the third state to declare a state of emergency because...

  • CHICAGO, May 1- Hog farmers are six times more likely than the general population to carry an infectious bacteria that can cause skin and respiratory problems and resists treatment from multiple drugs, according to a new U.S. research study. The study, published this week in the online journal Clinical Infectious Diseases, is the largest-ever examination of...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. The egg farm's owner, Rembrandt Foods, one of the top U.S. egg producers, confirmed the outbreak but disputed the number of birds affected.

  • Tandem Diabetes reports 1Q loss Thursday, 30 Apr 2015 | 7:09 PM ET

    SAN DIEGO _ Tandem Diabetes Care Inc. on Thursday reported a loss of $21.2 million in its first quarter. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • April 30- The U.S. Food and Drug Administration on Thursday approved The Medicines Co's dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The approval comes at a time Medicines Co is facing a drop in sales of its lead product, Angiomax anticoagulant injection, which accounted for over 80...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. Avian flu was "probable" at four other commercial farms in Buena Vista, Sioux and Clay counties, the Iowa Department of Agriculture and Land...

  • FDA approves Medicines Co's blood clotting agent Thursday, 30 Apr 2015 | 5:47 PM ET

    April 30- The U. S Food and Drug Administration approved the Medicines Co's dry powder blood clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The treatment, Raplixa, is a combination of two human plasma-derived blood-clotting proteins, fibrinogen and thrombin. Raplixa is used to control bleeding during...

  • LOS ANGELES, April 30- Gilead Sciences Inc said on Thursday its quarterly net profit nearly doubled, driven by sales of its novel hepatitis C drugs, as it topped Wall Street estimates. Excluding one-time items, Gilead earned $2.94 per share in the first quarter, outpacing the average Wall Street estimate of $2.32, according to Thomson Reuters I/B/E/S.

  • FOSTER CITY, Calif.— Gilead Sciences raked in $3.6 billion from sales of its newest hepatitis C pill, lifting the drugmaker's results past Wall Street expectations. Gilead Sciences Inc. said Thursday that its net income nearly doubled, and excluding one-time charges it reported a profit of $2.94 per share. Analysts expected net income of $2.31 per share on $6.76...

  • CHICAGO, April 30- An Iowa-based chicken broiler breeding farm has initially tested positive for the highly pathogenic H5 bird flu, the Iowa Department of Agriculture and Land Stewardship confirmed on Thursday. The facility in Kossuth County, Iowa, houses an estimated 19,000 birds, state officials said. The H5N2 strain has been reported in Arkansas, Idaho, Iowa,...

  • NEW YORK— Shares of Blueprint Medicines rose Thursday after the biotech cancer drug developer's initial public offering raised $146.6 million, above its expectations. Blueprint Medicines hopes to start human testing of two drugs this year. Blueprint Medicines Corp. initially filed for an IPO valued at up to $100 million.

  • Pharma: No standout performers   Thursday, 30 Apr 2015 | 11:50 AM ET
    Pharma: No standout performers

    The earnings season for pharmaceutical has gone well so far, with the markets being happy with European pharma results, says Suki Virji, news editor at Scrip Intelligence.

  • Bird flu found in hawk in western Minnesota Thursday, 30 Apr 2015 | 10:47 AM ET

    ST. PAUL, Minn.— A hawk in western Minnesota is the first wild bird in the state to test positive for the bird flu virus since the beginning of an outbreak that's killed more than 20 million birds in the Midwest this spring, state wildlife officials announced Thursday. Minnesota, the nation's largest turkey-producing state, has been hit hard by the flu, with nearly 4...

  • NEW YORK/ LONDON, April 30- Pfizer Inc is the mystery bidder for Swedish Orphan Biovitrum AB, the rare disease specialist which disclosed this week that a potential buyer had made a preliminary offer, people with knowledge of the situation said. Sobi did not identify its potential acquirer when it revealed on Monday that it had received an approach, but Biogen and...

  • April 29- Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. Amgen said on Wednesday that T-Vec was more effective in melanoma patients whose cancer had not spread to internal organs.

  • April 29- Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 22-1 supporting an approval for the therapy, talimogene laherparepvec or "T-Vec", an engineered virus that kills cancer...

  • This wearable robot helps people walk   Wednesday, 29 Apr 2015 | 4:40 AM ET
    This wearable robot helps people walk

    Nathan Harding, CEO and co-founder of Ekso Bionics, says the company has produced what is essentially a wearable robot that helps retrain anyone to walk.

  • Officials with the U.S. Department of Agriculture's Animal and Plant Health Inspection Service told Reuters the H5N2 virus- along with two other highly pathogenic strains of bird flu- will likely be passed among birds at breeding grounds in the northern United States and Canada through the summer. The USDA statement marks a shift in tone in the agency's...

  • FDA approves generic versions of schizophrenia drug Tuesday, 28 Apr 2015 | 5:26 PM ET

    WASHINGTON— The Food and Drug Administration said Tuesday it has approved the first generic versions of Abilify, the blockbuster pill used to treat schizophrenia and bipolar disorder. The agency approved generic versions of the drug from four companies: Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd....

  • Biogen takes on Alzheimer's   Tuesday, 28 Apr 2015 | 4:29 PM ET
    alzheimer's

    George Scangos, Biogen CEO, discusses progress in clinical trials for Alzheimer's treatments, and the outlook for its multiple sclerosis Tecfidera drug.